Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
Eli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read MoreEli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read MoreEli Lilly and Co. LLY, +0.49% said Thursday that its experimental obesity drug received a…
Read MoreA pair of new drugs offer something many Americans desperately want: a way to lose…
Read MoreHere is yet more bleak news about the obesity epidemic: Obesity isn’t just killing millions…
Read MorePeople who are overweight and obese face many difficulties their normal weight peers do not.…
Read MoreThere are times when I’m writing that I just stare out the window thinking. I…
Read More